BioCentury
ARTICLE | Company News

Therion extends NCI deal

February 14, 2000 8:00 AM UTC

Therion Biologics ( Cambridge, Mass.) extended for five years its two CRADAs with the National Cancer Institute to develop vaccines for cancer. ...